SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Kumm Persson Lowa)
 

Search: WFRF:(Kumm Persson Lowa) > High prevalence of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Ahmad, IrmaDepartment of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Department of Radiation Oncology, Stanford University, Stanford, CA, United States,Örebro Univ, Fac Med & Hlth, Dept Infect Dis, Örebro, Sweden. (author)

High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • 2023-02-02
  • Frontiers Media S.A.2023
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-104509
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-104509URI
  • https://doi.org/10.3389/fpubh.2023.1104267DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-205360URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-498893URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • BACKGROUND: The long-term sequelae after COVID-19 constitute a challenge to public health and increased knowledge is needed. We investigated the prevalence of self-reported persistent symptoms and reduced health-related quality of life (HRQoL) in relation to functional exercise capacity, 6 months after infection, and explored risk factors for COVID-19 sequalae.METHODS: This was a prospective, multicenter, cohort study including 434 patients. At 6 months, physical exercise capacity was assessed by a 1-minute sit-to-stand test (1MSTST) and persistent symptoms were reported and HRQoL was evaluated through the EuroQol 5-level 5-dimension (EQ-5D-5L) questionnaire. Patients with both persistent symptoms and reduced HRQoL were classified into a new definition of post-acute COVID syndrome, PACS+. Risk factors for developing persistent symptoms, reduced HRQoL and PACS+ were identified by multivariable Poisson regression.RESULTS: Persistent symptoms were experienced by 79% of hospitalized, and 59% of non-hospitalized patients at 6 months. Hospitalized patients had a higher prevalence of self-assessed reduced overall health (28 vs. 12%) and PACS+ (31 vs. 11%). PACS+ was associated with reduced exercise capacity but not with abnormal pulse/desaturation during 1MSTST. Hospitalization was the most important independent risk factor for developing persistent symptoms, reduced overall health and PACS+.CONCLUSION: Persistent symptoms and reduced HRQoL are common among COVID-19 survivors, but abnormal pulse and peripheral saturation during exercise could not distinguish patients with PACS+. Patients with severe infection requiring hospitalization were more likely to develop PACS+, hence these patients should be prioritized for clinical follow-up after COVID-19.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Edin, Alicia,1985-Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Umeå Univ, Dept Surg & Perioperat Sci, Umeå, Sweden.(Swepub:umu)alalid03 (author)
  • Granvik, ChristofferUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)chgr0038 (author)
  • Kumm Persson, LowaUmeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Umeå Univ, Dept Surg & Perioperat Sci, Umeå, Sweden. (author)
  • Tevell, Staffan,1975-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases, Karlstad Hospital, Karlstad, Sweden; Centre for Clinical Research and Education, Region Värmland, Karlstad, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Karlstad Hosp, Dept Infect Dis, Karlstad, Sweden.;Ctr Clin Res & Educ, Karlstad, Sweden.;Örebro Univ, Fac Med & Hlth, Sch Med Sci, Örebro, Sweden.(Swepub:oru)stl (author)
  • Månsson, EmeliUppsala universitet,Centrum för klinisk forskning, Västerås (author)
  • Magnuson, AndersCenter for Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, School of Medical Sciences, Örebro University, Örebro, Sweden,Örebro Univ, Fac Med & Hlth, Ctr Clin Epidemiol & Biostat, Sch Med Sci, Örebro, Sweden. (author)
  • Marklund, IngelaUmeå universitet,Institutionen för samhällsmedicin och rehabilitering,Centre for Clinical Research and Education, Region Värmland, Karlstad, Sweden,Ctr Clin Res & Educ, Karlstad, Sweden.;Umeå Univ, Dept Community Med & Rehabil, Umeå, Sweden.(Swepub:umu)inamad99 (author)
  • Persson, Ida-LisaUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)idpe0053 (author)
  • Kauppi, AnnaUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)anakai97 (author)
  • Ahlm, Clas,1956-Umeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)clah0001 (author)
  • Forsell, Mattias N. E.Umeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)mafo0173 (author)
  • Sundh, Josefin,1972-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Örebro Univ, Fac Med & Hlth, Dept Resp Med, Örebro, Sweden.(Swepub:oru)jnsh (author)
  • Lange, Anna,1975-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Department of Infectious Diseases,Department of Radiation Oncology, Stanford University, Stanford, CA, United States,Örebro Univ, Fac Med & Hlth, Dept Infect Dis, Örebro, Sweden.(Swepub:oru)aalg (author)
  • Cajander, Sara,1980-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, Sweden,Department of Radiation Oncology, Stanford University, Stanford, CA, United States,Örebro Univ, Fac Med & Hlth, Dept Infect Dis, Örebro, Sweden.(Swepub:oru)scr (author)
  • Normark, JohanUmeå universitet,Institutionen för klinisk mikrobiologi,Umeå Univ, Dept Clin Microbiol, Umeå, Sweden.(Swepub:umu)jono0053 (author)
  • Department of Infectious Diseases, Faculty of Medicine and Health, Örebro University, Örebro, SwedenDepartment of Radiation Oncology, Stanford University, Stanford, CA, United States (creator_code:org_t)

Related titles

  • In:Frontiers In Public Health: Frontiers Media S.A.112296-2565

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view